Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging

Deposition of amyloid plaques in the brain is one of the two main pathological hallmarks of Alzheimer’s disease (AD). Amyloid positron emission tomography (PET) is a neuroimaging tool that selectively detects in vivo amyloid deposition in the brain and is a reliable endophenotype for AD that complem...

Full description

Saved in:
Bibliographic Details
Published inMolecular psychiatry Vol. 26; no. 1; pp. 309 - 321
Main Authors Yan, Qi, Nho, Kwangsik, Del-Aguila, Jorge L., Wang, Xingbin, Risacher, Shannon L., Fan, Kang-Hsien, Snitz, Beth E., Aizenstein, Howard J., Mathis, Chester A., Lopez, Oscar L., Demirci, F. Yesim, Feingold, Eleanor, Klunk, William E., Saykin, Andrew J., Cruchaga, Carlos, Kamboh, M. Ilyas
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.01.2021
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN1359-4184
1476-5578
1476-5578
DOI10.1038/s41380-018-0246-7

Cover

Abstract Deposition of amyloid plaques in the brain is one of the two main pathological hallmarks of Alzheimer’s disease (AD). Amyloid positron emission tomography (PET) is a neuroimaging tool that selectively detects in vivo amyloid deposition in the brain and is a reliable endophenotype for AD that complements cerebrospinal fluid biomarkers with regional information. We measured in vivo amyloid deposition in the brains of ~1000 subjects from three collaborative AD centers and ADNI using 11 C-labeled Pittsburgh Compound-B (PiB)-PET imaging followed by meta-analysis of genome-wide association studies, first to our knowledge for PiB-PET, to identify novel genetic loci for this endophenotype. The APOE region showed the most significant association where several SNPs surpassed the genome-wide significant threshold, with APOE*4 being most significant ( P -meta = 9.09E-30; β  = 0.18). Interestingly, after conditioning on APOE*4 , 14 SNPs remained significant at P  < 0.05 in the APOE region that were not in linkage disequilibrium with APOE*4 . Outside the APOE region, the meta-analysis revealed 15 non- APOE loci with P  < 1E-05 on nine chromosomes, with two most significant SNPs on chromosomes 8 ( P- meta = 4.87E-07) and 3 ( P- meta = 9.69E-07). Functional analyses of these SNPs indicate their potential relevance with AD pathogenesis. Top 15 non- APOE SNPs along with APOE*4 explained 25–35% of the amyloid variance in different datasets, of which 14–17% was explained by APOE*4 alone. In conclusion, we have identified novel signals in APOE and non- APOE regions that affect amyloid deposition in the brain. Our data also highlights the presence of yet to be discovered variants that may be responsible for the unexplained genetic variance of amyloid deposition.
AbstractList Deposition of amyloid plaques in the brain is one of the two main pathological hallmarks of Alzheimer's disease (AD). Amyloid positron emission tomography (PET) is a neuroimaging tool that selectively detects in vivo amyloid deposition in the brain and is a reliable endophenotype for AD that complements cerebrospinal fluid biomarkers with regional information. We measured in vivo amyloid deposition in the brains of ~1000 subjects from three collaborative AD centers and ADNI using .sup.11C-labeled Pittsburgh Compound-B (PiB)-PET imaging followed by meta-analysis of genome-wide association studies, first to our knowledge for PiB-PET, to identify novel genetic loci for this endophenotype. The APOE region showed the most significant association where several SNPs surpassed the genome-wide significant threshold, with APOE*4 being most significant (P-meta = 9.09E-30; [beta] = 0.18). Interestingly, after conditioning on APOE*4, 14 SNPs remained significant at P < 0.05 in the APOE region that were not in linkage disequilibrium with APOE*4. Outside the APOE region, the meta-analysis revealed 15 non-APOE loci with P < 1E-05 on nine chromosomes, with two most significant SNPs on chromosomes 8 (P-meta = 4.87E-07) and 3 (P-meta = 9.69E-07). Functional analyses of these SNPs indicate their potential relevance with AD pathogenesis. Top 15 non-APOE SNPs along with APOE*4 explained 25-35% of the amyloid variance in different datasets, of which 14-17% was explained by APOE*4 alone. In conclusion, we have identified novel signals in APOE and non-APOE regions that affect amyloid deposition in the brain. Our data also highlights the presence of yet to be discovered variants that may be responsible for the unexplained genetic variance of amyloid deposition.
Deposition of amyloid plaques in the brain is one of the two main pathological hallmarks of Alzheimer’s disease (AD). Amyloid positron emission tomography (PET) is a neuroimaging tool that selectively detects in vivo amyloid deposition in the brain and is a reliable endophenotype for AD that complements cerebrospinal fluid biomarkers with regional information. We measured in vivo amyloid deposition in the brains of ~1000 subjects from three collaborative AD centers and ADNI using 11C-labeled Pittsburgh Compound-B (PiB)-PET imaging followed by meta-analysis of genome-wide association studies, first to our knowledge for PiB-PET, to identify novel genetic loci for this endophenotype. The APOE region showed the most significant association where several SNPs surpassed the genome-wide significant threshold, with APOE*4 being most significant (P-meta = 9.09E-30; β = 0.18). Interestingly, after conditioning on APOE*4, 14 SNPs remained significant at P < 0.05 in the APOE region that were not in linkage disequilibrium with APOE*4. Outside the APOE region, the meta-analysis revealed 15 non-APOE loci with P < 1E-05 on nine chromosomes, with two most significant SNPs on chromosomes 8 (P-meta = 4.87E-07) and 3 (P-meta = 9.69E-07). Functional analyses of these SNPs indicate their potential relevance with AD pathogenesis. Top 15 non-APOE SNPs along with APOE*4 explained 25–35% of the amyloid variance in different datasets, of which 14–17% was explained by APOE*4 alone. In conclusion, we have identified novel signals in APOE and non-APOE regions that affect amyloid deposition in the brain. Our data also highlights the presence of yet to be discovered variants that may be responsible for the unexplained genetic variance of amyloid deposition.
Deposition of amyloid plaques in the brain is one of the two main pathological hallmarks of Alzheimer’s disease (AD). Amyloid positron emission tomography (PET) is a neuroimaging tool that selectively detects in vivo amyloid deposition in the brain and is a reliable endophenotype for AD that complements cerebrospinal fluid biomarkers with regional information. We measured in vivo amyloid deposition in the brains of ~1000 subjects from three collaborative AD centers and ADNI using 11 C-labeled Pittsburgh Compound-B (PiB)-PET imaging followed by meta-analysis of genome-wide association studies, first to our knowledge for PiB-PET, to identify novel genetic loci for this endophenotype. The APOE region showed the most significant association where several SNPs surpassed the genome-wide significant threshold, with APOE*4 being most significant ( P -meta = 9.09E-30; β  = 0.18). Interestingly, after conditioning on APOE*4 , 14 SNPs remained significant at P  < 0.05 in the APOE region that were not in linkage disequilibrium with APOE*4 . Outside the APOE region, the meta-analysis revealed 15 non- APOE loci with P  < 1E-05 on nine chromosomes, with two most significant SNPs on chromosomes 8 ( P- meta = 4.87E-07) and 3 ( P- meta = 9.69E-07). Functional analyses of these SNPs indicate their potential relevance with AD pathogenesis. Top 15 non- APOE SNPs along with APOE*4 explained 25–35% of the amyloid variance in different datasets, of which 14–17% was explained by APOE*4 alone. In conclusion, we have identified novel signals in APOE and non- APOE regions that affect amyloid deposition in the brain. Our data also highlights the presence of yet to be discovered variants that may be responsible for the unexplained genetic variance of amyloid deposition.
Deposition of amyloid plaques in the brain is one of the two main pathological hallmarks of Alzheimer's disease (AD). Amyloid positron emission tomography (PET) is a neuroimaging tool that selectively detects in vivo amyloid deposition in the brain and is a reliable endophenotype for AD that complements cerebrospinal fluid biomarkers with regional information. We measured in vivo amyloid deposition in the brains of ~1000 subjects from three collaborative AD centers and ADNI using C-labeled Pittsburgh Compound-B (PiB)-PET imaging followed by meta-analysis of genome-wide association studies, first to our knowledge for PiB-PET, to identify novel genetic loci for this endophenotype. The APOE region showed the most significant association where several SNPs surpassed the genome-wide significant threshold, with APOE*4 being most significant (P-meta = 9.09E-30; β = 0.18). Interestingly, after conditioning on APOE*4, 14 SNPs remained significant at P < 0.05 in the APOE region that were not in linkage disequilibrium with APOE*4. Outside the APOE region, the meta-analysis revealed 15 non-APOE loci with P < 1E-05 on nine chromosomes, with two most significant SNPs on chromosomes 8 (P-meta = 4.87E-07) and 3 (P-meta = 9.69E-07). Functional analyses of these SNPs indicate their potential relevance with AD pathogenesis. Top 15 non-APOE SNPs along with APOE*4 explained 25-35% of the amyloid variance in different datasets, of which 14-17% was explained by APOE*4 alone. In conclusion, we have identified novel signals in APOE and non-APOE regions that affect amyloid deposition in the brain. Our data also highlights the presence of yet to be discovered variants that may be responsible for the unexplained genetic variance of amyloid deposition.
Deposition of amyloid plaques in the brain is one of the two main pathological hallmarks of Alzheimer's disease (AD). Amyloid positron emission tomography (PET) is a neuroimaging tool that selectively detects in vivo amyloid deposition in the brain and is a reliable endophenotype for AD that complements cerebrospinal fluid biomarkers with regional information. We measured in vivo amyloid deposition in the brains of ~1000 subjects from three collaborative AD centers and ADNI using 11C-labeled Pittsburgh Compound-B (PiB)-PET imaging followed by meta-analysis of genome-wide association studies, first to our knowledge for PiB-PET, to identify novel genetic loci for this endophenotype. The APOE region showed the most significant association where several SNPs surpassed the genome-wide significant threshold, with APOE*4 being most significant (P-meta = 9.09E-30; β = 0.18). Interestingly, after conditioning on APOE*4, 14 SNPs remained significant at P < 0.05 in the APOE region that were not in linkage disequilibrium with APOE*4. Outside the APOE region, the meta-analysis revealed 15 non-APOE loci with P < 1E-05 on nine chromosomes, with two most significant SNPs on chromosomes 8 (P-meta = 4.87E-07) and 3 (P-meta = 9.69E-07). Functional analyses of these SNPs indicate their potential relevance with AD pathogenesis. Top 15 non-APOE SNPs along with APOE*4 explained 25-35% of the amyloid variance in different datasets, of which 14-17% was explained by APOE*4 alone. In conclusion, we have identified novel signals in APOE and non-APOE regions that affect amyloid deposition in the brain. Our data also highlights the presence of yet to be discovered variants that may be responsible for the unexplained genetic variance of amyloid deposition.Deposition of amyloid plaques in the brain is one of the two main pathological hallmarks of Alzheimer's disease (AD). Amyloid positron emission tomography (PET) is a neuroimaging tool that selectively detects in vivo amyloid deposition in the brain and is a reliable endophenotype for AD that complements cerebrospinal fluid biomarkers with regional information. We measured in vivo amyloid deposition in the brains of ~1000 subjects from three collaborative AD centers and ADNI using 11C-labeled Pittsburgh Compound-B (PiB)-PET imaging followed by meta-analysis of genome-wide association studies, first to our knowledge for PiB-PET, to identify novel genetic loci for this endophenotype. The APOE region showed the most significant association where several SNPs surpassed the genome-wide significant threshold, with APOE*4 being most significant (P-meta = 9.09E-30; β = 0.18). Interestingly, after conditioning on APOE*4, 14 SNPs remained significant at P < 0.05 in the APOE region that were not in linkage disequilibrium with APOE*4. Outside the APOE region, the meta-analysis revealed 15 non-APOE loci with P < 1E-05 on nine chromosomes, with two most significant SNPs on chromosomes 8 (P-meta = 4.87E-07) and 3 (P-meta = 9.69E-07). Functional analyses of these SNPs indicate their potential relevance with AD pathogenesis. Top 15 non-APOE SNPs along with APOE*4 explained 25-35% of the amyloid variance in different datasets, of which 14-17% was explained by APOE*4 alone. In conclusion, we have identified novel signals in APOE and non-APOE regions that affect amyloid deposition in the brain. Our data also highlights the presence of yet to be discovered variants that may be responsible for the unexplained genetic variance of amyloid deposition.
Audience Academic
Author Nho, Kwangsik
Del-Aguila, Jorge L.
Risacher, Shannon L.
Yan, Qi
Aizenstein, Howard J.
Feingold, Eleanor
Wang, Xingbin
Snitz, Beth E.
Klunk, William E.
Lopez, Oscar L.
Fan, Kang-Hsien
Mathis, Chester A.
Saykin, Andrew J.
Cruchaga, Carlos
Demirci, F. Yesim
Kamboh, M. Ilyas
Author_xml – sequence: 1
  givenname: Qi
  surname: Yan
  fullname: Yan, Qi
  organization: Department of Human Genetics, University of Pittsburgh, Department of Pediatrics, Children’s Hospital of Pittsburgh of UPMC, University of Pittsburgh
– sequence: 2
  givenname: Kwangsik
  surname: Nho
  fullname: Nho, Kwangsik
  organization: Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indiana Alzheimer Disease Center, Indiana University School of Medicine
– sequence: 3
  givenname: Jorge L.
  orcidid: 0000-0002-6364-8707
  surname: Del-Aguila
  fullname: Del-Aguila, Jorge L.
  organization: Department of Psychiatry, Washington University School of Medicine
– sequence: 4
  givenname: Xingbin
  surname: Wang
  fullname: Wang, Xingbin
  organization: Department of Human Genetics, University of Pittsburgh
– sequence: 5
  givenname: Shannon L.
  surname: Risacher
  fullname: Risacher, Shannon L.
  organization: Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indiana Alzheimer Disease Center, Indiana University School of Medicine
– sequence: 6
  givenname: Kang-Hsien
  surname: Fan
  fullname: Fan, Kang-Hsien
  organization: Department of Human Genetics, University of Pittsburgh
– sequence: 7
  givenname: Beth E.
  surname: Snitz
  fullname: Snitz, Beth E.
  organization: Department of Neurology, University of Pittsburgh, Alzheimer Disease Research Center, University of Pittsburgh
– sequence: 8
  givenname: Howard J.
  surname: Aizenstein
  fullname: Aizenstein, Howard J.
  organization: Department of Psychiatry, University of Pittsburgh
– sequence: 9
  givenname: Chester A.
  surname: Mathis
  fullname: Mathis, Chester A.
  organization: Alzheimer Disease Research Center, University of Pittsburgh, Department of Radiology, University of Pittsburgh
– sequence: 10
  givenname: Oscar L.
  surname: Lopez
  fullname: Lopez, Oscar L.
  organization: Department of Neurology, University of Pittsburgh, Alzheimer Disease Research Center, University of Pittsburgh, Department of Psychiatry, University of Pittsburgh
– sequence: 11
  givenname: F. Yesim
  surname: Demirci
  fullname: Demirci, F. Yesim
  organization: Department of Human Genetics, University of Pittsburgh
– sequence: 12
  givenname: Eleanor
  surname: Feingold
  fullname: Feingold, Eleanor
  organization: Department of Human Genetics, University of Pittsburgh
– sequence: 13
  givenname: William E.
  orcidid: 0000-0001-5512-0251
  surname: Klunk
  fullname: Klunk, William E.
  organization: Department of Neurology, University of Pittsburgh, Alzheimer Disease Research Center, University of Pittsburgh, Department of Psychiatry, University of Pittsburgh
– sequence: 14
  givenname: Andrew J.
  orcidid: 0000-0002-1376-8532
  surname: Saykin
  fullname: Saykin, Andrew J.
  organization: Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indiana Alzheimer Disease Center, Indiana University School of Medicine
– sequence: 16
  givenname: Carlos
  surname: Cruchaga
  fullname: Cruchaga, Carlos
  organization: Department of Psychiatry, Washington University School of Medicine
– sequence: 17
  givenname: M. Ilyas
  surname: Kamboh
  fullname: Kamboh, M. Ilyas
  email: kamboh@pitt.edu
  organization: Department of Human Genetics, University of Pittsburgh, Alzheimer Disease Research Center, University of Pittsburgh, Department of Psychiatry, University of Pittsburgh
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30361487$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1DAUhSNURB_wA9ggS2zKwsWv2M4GqR2VFqkSsyhry3Gc1FViBzsBzb_HmSlDWwHKwpH9net7fM9xceCDt0XxFqMzjKj8mBimEkGEJUSEcSheFEeYCQ7LUsiD_E_LCjIs2WFxnNI9Qsth-ao4pIhyzKQ4KsYr68Ng4U_XWKBTCsbpyQUP0jQ3GxBaUEftPNDDpg-uAY0dQ3JbQicwWJ3maBtQb8DaTVOq59jdgVUYxjD7Bl6A07W7-ADXl7fADbpzvntdvGx1n-ybh_Wk-Pb58nZ1DW--Xn1Znd9AU1IxwVoiWnKsjSCkYo2VgpOyRlpgUVdlyyrD6q0LimmVjfGyJRaXmFArFm_0pPi0qzvO9WAbY_0Uda_GmPuIGxW0U09PvLtTXfihOMEV40uB04cCMXyfbZrU4JKxfa-9DXNSBBNeIV5hkdH3z9D7MEef7SnChJRcytzYnup0b5Xzbcj3mqWoOud5YohghDJ19hcqf40dnMnzb13efyJ499jo3uHvGWcA7wATQ0rRtnsEI7XkSO1ypHKO1JIjtWjEM41x0zYYuRvX_1dJdsqUb_GdjX_e4t-iX5ds2Lk
CitedBy_id crossref_primary_10_1016_j_ebiom_2023_104511
crossref_primary_10_1186_s13024_023_00633_4
crossref_primary_10_1038_s41588_022_01039_6
crossref_primary_10_1093_geronb_gbae172
crossref_primary_10_1007_s13311_021_01152_0
crossref_primary_10_1016_j_neurobiolaging_2022_02_016
crossref_primary_10_1038_s41586_021_03489_0
crossref_primary_10_1007_s00401_022_02419_2
crossref_primary_10_3233_JAD_220164
crossref_primary_10_1186_s40478_023_01563_4
crossref_primary_10_1007_s12640_019_00105_y
crossref_primary_10_1186_s13024_022_00592_2
crossref_primary_10_3233_JAD_200671
crossref_primary_10_1038_s41582_018_0106_8
crossref_primary_10_3389_fphys_2024_1395371
crossref_primary_10_1016_j_xcrm_2024_101735
crossref_primary_10_1186_s13073_025_01444_6
crossref_primary_10_1002_alz_13880
crossref_primary_10_1186_s13195_023_01362_y
crossref_primary_10_1001_jamaneurol_2024_1755
crossref_primary_10_1093_brain_awae176
crossref_primary_10_1038_s41598_024_71217_5
crossref_primary_10_1002_ejoc_202200482
crossref_primary_10_1038_s41467_024_52298_2
crossref_primary_10_1093_brain_awac392
crossref_primary_10_1371_journal_pone_0267298
crossref_primary_10_1371_journal_pone_0272368
crossref_primary_10_3390_vaccines11111706
crossref_primary_10_3389_fnagi_2023_1160536
crossref_primary_10_1038_s41380_020_0731_7
crossref_primary_10_1001_jamaneurol_2020_1760
crossref_primary_10_1002_alz_13427
crossref_primary_10_1016_j_nbd_2023_106373
crossref_primary_10_1186_s13195_021_00854_z
crossref_primary_10_1186_s40035_022_00315_z
crossref_primary_10_1038_s41380_023_02170_4
crossref_primary_10_1007_s00018_022_04614_6
crossref_primary_10_1016_j_cmpb_2023_107450
crossref_primary_10_1111_ahg_12520
crossref_primary_10_1007_s11682_020_00334_2
crossref_primary_10_1093_braincomms_fcz047
crossref_primary_10_1016_j_celrep_2023_112375
Cites_doi 10.1016/S1474-4422(12)70142-4
10.1038/ijo.2015.217
10.1016/j.jalz.2010.03.003
10.1007/s00401-013-1185-7
10.1016/j.tips.2015.03.002
10.1016/j.brainresbull.2017.03.010
10.1016/j.jalz.2011.10.007
10.1002/ana.23797
10.1016/S1474-4422(12)70291-0
10.1038/mp.2013.19
10.1002/ana.21843
10.1038/nature09534
10.1016/j.pneurobio.2018.05.001
10.3346/jkms.2016.31.8.1208
10.1016/j.jalz.2015.05.009
10.1146/annurev-neuro-071013-014300
10.1016/S1474-4422(16)30125-9
10.1001/jamaneurol.2014.1491
10.1038/ng.801
10.1016/j.neuron.2017.11.013
10.1038/jhg.2015.141
10.2174/1871527313666140806124850
10.1002/ana.20009
10.3389/fnagi.2013.00011
10.1002/da.22260
10.1016/j.neuropsychologia.2013.07.017
10.1038/sj.jcbfm.9600146
10.1371/journal.pcbi.1004219
10.1038/ng.3914
10.7554/eLife.02236
10.1016/j.cell.2016.12.044
10.1371/journal.pgen.1004269
10.1007/s11682-011-9136-1
10.1212/01.wnl.0000228230.26044.a4
10.1038/ng.2802
10.1111/acer.12060
10.1016/j.biocel.2015.06.001
10.1016/j.cell.2013.02.012
10.1093/bioinformatics/btq340
10.1073/pnas.0611236104
10.1016/j.jalz.2015.02.004
10.1371/journal.pgen.1000529
10.1001/jamaneurol.2014.4144
10.1038/tp.2012.45
10.1016/j.neuroimage.2013.01.015
10.2147/CIA.S107037
10.1016/j.neurobiolaging.2016.02.024
10.1016/j.ejmg.2017.03.007
10.1016/S1474-4422(15)00323-3
10.1038/tp.2014.2
10.1038/mp.2011.135
10.1007/s00401-017-1685-y
ContentType Journal Article
Copyright The Author(s) 2018
COPYRIGHT 2021 Nature Publishing Group
The Author(s) 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2018
– notice: COPYRIGHT 2021 Nature Publishing Group
– notice: The Author(s) 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
CorporateAuthor for the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
CorporateAuthor_xml – name: for the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
– name: Alzheimer’s Disease Neuroimaging Initiative (ADNI)
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
88G
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
5PM
DOI 10.1038/s41380-018-0246-7
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
Medical Database
Psychology Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
ProQuest One Psychology

MEDLINE
CrossRef
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1476-5578
EndPage 321
ExternalDocumentID PMC6219464
A655702100
30361487
10_1038_s41380_018_0246_7
Genre Research Support, U.S. Gov't, Non-P.H.S
Meta-Analysis
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
United States--US
Pittsburgh Pennsylvania
GeographicLocations_xml – name: United States
– name: United States--US
– name: Pittsburgh Pennsylvania
GrantInformation_xml – fundername: U.S. Department of Defense (DOD)
  grantid: W81XWH-12-2-0012
  funderid: https://doi.org/10.13039/100000005
– fundername: NIH: AG030653, AG041718, AG005133
– fundername: NIH: AG005133, AG025204
– fundername: NIH: AG044546, AG003991, AG053303
– fundername: NIH: AG025516, AG025204
– fundername: NIH: AG054936, LM012535
– fundername: NIA NIH HHS
  grantid: P50 AG005133
– fundername: NIA NIH HHS
  grantid: R01 AG030653
– fundername: NIA NIH HHS
  grantid: R01 AG052521
– fundername: NIA NIH HHS
  grantid: R01 AG041718
– fundername: NIA NIH HHS
  grantid: P01 AG003991
– fundername: NLM NIH HHS
  grantid: R01 LM012535
– fundername: NIA NIH HHS
  grantid: U24 AG021886
– fundername: NIA NIH HHS
  grantid: RF1 AG053303
– fundername: NIA NIH HHS
  grantid: P30 AG066468
– fundername: NIA NIH HHS
  grantid: R03 AG054936
– fundername: ;
– fundername: ;
  grantid: W81XWH-12-2-0012
GroupedDBID ---
-Q-
0R~
123
29M
2WC
36B
39C
3V.
4.4
406
53G
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAYZH
AAZLF
ABAKF
ABAWZ
ABDBF
ABIVO
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFS
ACKTT
ACPRK
ACRQY
ACUHS
ACZOJ
ADBBV
ADHDB
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AXYYD
AZQEC
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
C6C
CAG
CCPQU
COF
CS3
DIK
DNIVK
DPUIP
DU5
DWQXO
E3Z
EAD
EAP
EBC
EBD
EBLON
EBS
EE.
EIOEI
EJD
EMB
EMK
EMOBN
EPL
EPS
ESX
F5P
FDQFY
FEDTE
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GNUQQ
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IHR
INH
INR
IPY
ITC
IWAJR
JSO
JZLTJ
KQ8
M1P
M2M
M7P
NAO
NQJWS
O9-
OK1
OVD
P2P
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
RNS
RNT
RNTTT
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
TUS
UKHRP
~8M
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
AEIIB
PMFND
7TK
7XB
8FE
8FH
8FK
K9.
LK8
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c537t-b803561ac72294de87625b0a717b95f49c4b30361313900165f2e15123e736143
IEDL.DBID C6C
ISSN 1359-4184
1476-5578
IngestDate Thu Aug 21 14:31:58 EDT 2025
Fri Sep 05 08:18:03 EDT 2025
Sat Aug 23 14:03:28 EDT 2025
Tue Jun 17 21:42:48 EDT 2025
Tue Jun 10 20:40:27 EDT 2025
Mon Jul 21 06:02:09 EDT 2025
Tue Jul 01 00:21:50 EDT 2025
Thu Apr 24 22:58:46 EDT 2025
Fri Feb 21 02:39:28 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c537t-b803561ac72294de87625b0a717b95f49c4b30361313900165f2e15123e736143
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-6364-8707
0000-0002-1376-8532
0000-0001-5512-0251
OpenAccessLink https://www.nature.com/articles/s41380-018-0246-7
PMID 30361487
PQID 2478868812
PQPubID 44096
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6219464
proquest_miscellaneous_2126906917
proquest_journals_2478868812
gale_infotracmisc_A655702100
gale_infotracacademiconefile_A655702100
pubmed_primary_30361487
crossref_primary_10_1038_s41380_018_0246_7
crossref_citationtrail_10_1038_s41380_018_0246_7
springer_journals_10_1038_s41380_018_0246_7
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-01-01
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – month: 01
  year: 2021
  text: 2021-01-01
  day: 01
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
– name: New York
PublicationTitle Molecular psychiatry
PublicationTitleAbbrev Mol Psychiatry
PublicationTitleAlternate Mol Psychiatry
PublicationYear 2021
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Nebes, Snitz, Cohen, Aizenstein, Saxton, Halligan (CR18) 2013; 51
Swaminathan, Shen, Risacher, Yoder, West, Kim (CR20) 2012; 6
Chaurasia, Park, Seo, Park (CR52) 2016; 31
Geering (CR44) 2015; 65
Deters, Risacher, Yoder, Oblak, Unverzagt, Murrell (CR23) 2016; 6
Kim, You, Chen, Suh, Tanzi, Ho Lee (CR45) 2016; 25
Klunk, Engler, Nordberg, Wang, Blomqvist, Holt (CR8) 2004; 55
Naj, Jun, Reitz, Kunkle, Perry, Park (CR16) 2014; 71
Ruiz, Heilmann, Becker, Hernandez, Wagner, Thelen (CR46) 2014; 4
Wolf, Rasmusson, Mitchell, Logue, Baldwin, Miller (CR37) 2014; 31
Curtis, Gamez, Singh, Sadowsky, Villena, Sabbagh (CR13) 2015; 72
Utine, Taskiran, Kosukcu, Karaosmanoglu, Guleray, Dogan (CR48) 2017; 60
Willer, Li, Abecasis (CR28) 2010; 26
Deming, Li, Kapoor, Harari, Del-Aguila, Black (CR33) 2017; 133
Flajolet, He, Heiman, Lin, Nairn, Greengard (CR47) 2007; 104
Hyman, Phelps, Beach, Bigio, Cairns, Carrillo (CR4) 2012; 8
de Leeuw, Mooij, Heskes, Posthuma (CR31) 2015; 11
Kamboh, Demirci, Wang, Minster, Carrasquillo, Pankratz (CR29) 2012; 2
Jack, Therneau, Wiste, Weigand, Knopman, Lowe (CR6) 2016; 15
Jagust, Bandy, Chen, Foster, Landau, Mathis (CR22) 2010; 6
Ramanan, Risacher, Nho, Kim, Swaminathan, Shen (CR32) 2014; 19
Genomes Project, Abecasis, Altshuler, Auton, Brooks, Durbin (CR27) 2010; 467
Clark, Pontecorvo, Beach, Bedell, Coleman, Doraiswamy (CR11) 2012; 11
Howie, Donnelly, Marchini (CR26) 2009; 5
Saykin, Shen, Yao, Kim, Nho, Risacher (CR21) 2015; 11
Price, Klunk, Lopresti, Lu, Hoge, Ziolko (CR9) 2005; 25
Mathis, Kuller, Klunk, Snitz, Price, Weissfeld (CR17) 2013; 73
Burnham, Bourgeat, Dore, Savage, Brown, Laws (CR7) 2016; 15
Sabri, Sabbagh, Seibyl, Barthel, Akatsu, Ouchi (CR12) 2015; 11
Blennow, Mattsson, Scholl, Hansson, Zetterberg (CR14) 2015; 36
Mintun, Larossa, Sheline, Dence, Lee, Mach (CR25) 2006; 67
Liu, Zhao, Fu, Wang, Linares, Tsai (CR36) 2017; 96
Hashimoto, Nakazawa, Tsurusaki, Yasuda, Nagayasu, Matsumura (CR49) 2016; 61
Luo, Chen (CR41) 2016; 11
Shi, Zhang, Qin (CR42) 2017; 132
Cohen, Mowrey, Weissfeld, Aizenstein, McDade, Mountz (CR30) 2013; 71
Visscher, Hemani, Vinkhuyzen, Chen, Lee, Wray (CR54) 2014; 10
Jack, Barrio, Kepe (CR10) 2013; 126
Huang, Zhou, Wernig, Sudhof (CR35) 2017; 168
Lambert, Ibrahim-Verbaas, Harold, Naj, Sims, Bellenguez (CR2) 2013; 45
Kamboh, Barmada, Demirci, Minster, Carrasquillo, Pankratz (CR15) 2012; 17
Sung, Perusse, Sarzynski, Fornage, Sidney, Sternfeld (CR38) 2016; 40
Klarin, Zhu, Emdin, Chaffin, Horner, McMillan (CR43) 2017; 49
Naj, Jun, Beecham, Wang, Vardarajan, Buros (CR1) 2011; 43
Jack, Knopman, Jagust, Petersen, Weiner, Aisen (CR5) 2013; 12
Yu, Tan, Hardy (CR34) 2014; 37
Procopio, Saba, Walter, Lesch, Skala, Schlaff (CR39) 2013; 37
Xiong, Zhao, Tang, Wei, Thomas, Wang (CR50) 2014; 3
Gambuzza, Sofo, Salmeri, Soraci, Marino, Bramanti (CR53) 2014; 13
Morris, Roe, Xiong, Fagan, Goate, Holtzman (CR19) 2010; 67
Batista, Chang (CR40) 2013; 152
Ridge, Hoyt, Boehme, Mukherjee, Crane, Haines (CR3) 2016; 41
Risacher, Kim, Shen, Nho, Foroud, Green (CR24) 2013; 5
Jazvinscak Jembrek, Slade, Hof, Simic (CR51) 2018; 168
C Shi (246_CR42) 2017; 132
CM Clark (246_CR11) 2012; 11
JC Lambert (246_CR2) 2013; 45
S Swaminathan (246_CR20) 2012; 6
A Chaurasia (246_CR52) 2016; 31
PM Visscher (246_CR54) 2014; 10
WJ Jagust (246_CR22) 2010; 6
DO Procopio (246_CR39) 2013; 37
Y Deming (246_CR33) 2017; 133
R Hashimoto (246_CR49) 2016; 61
CA de Leeuw (246_CR31) 2015; 11
MI Kamboh (246_CR15) 2012; 17
EJ Wolf (246_CR37) 2014; 31
AD Cohen (246_CR30) 2013; 71
PJ Batista (246_CR40) 2013; 152
BT Hyman (246_CR4) 2012; 8
MI Kamboh (246_CR29) 2012; 2
SL Risacher (246_CR24) 2013; 5
WE Klunk (246_CR8) 2004; 55
C Genomes Project (246_CR27) 2010; 467
B Geering (246_CR44) 2015; 65
KD Deters (246_CR23) 2016; 6
O Sabri (246_CR12) 2015; 11
VK Ramanan (246_CR32) 2014; 19
JT Yu (246_CR34) 2014; 37
YJ Sung (246_CR38) 2016; 40
CR Jack Jr (246_CR6) 2016; 15
YA Huang (246_CR35) 2017; 168
CR Jack Jr (246_CR10) 2013; 126
A Ruiz (246_CR46) 2014; 4
AJ Saykin (246_CR21) 2015; 11
CC Liu (246_CR36) 2017; 96
AC Naj (246_CR1) 2011; 43
D Klarin (246_CR43) 2017; 49
RD Nebes (246_CR18) 2013; 51
JC Morris (246_CR19) 2010; 67
CA Mathis (246_CR17) 2013; 73
BM Kim (246_CR45) 2016; 25
MA Mintun (246_CR25) 2006; 67
GE Utine (246_CR48) 2017; 60
Q Luo (246_CR41) 2016; 11
M Jazvinscak Jembrek (246_CR51) 2018; 168
SC Burnham (246_CR7) 2016; 15
C Curtis (246_CR13) 2015; 72
PG Ridge (246_CR3) 2016; 41
AC Naj (246_CR16) 2014; 71
CR Jack Jr. (246_CR5) 2013; 12
X Xiong (246_CR50) 2014; 3
K Blennow (246_CR14) 2015; 36
CJ Willer (246_CR28) 2010; 26
JC Price (246_CR9) 2005; 25
M Flajolet (246_CR47) 2007; 104
BN Howie (246_CR26) 2009; 5
ME Gambuzza (246_CR53) 2014; 13
References_xml – volume: 25
  start-page: 2498
  year: 2016
  end-page: 513
  ident: CR45
  article-title: Inhibition of death-associated protein kinase 1 attenuates the phosphorylation and amyloidogenic processing of amyloid precursor protein
  publication-title: Hum Mol Genet
– volume: 11
  start-page: e1004219
  year: 2015
  ident: CR31
  article-title: MAGMA: generalized gene-set analysis of GWAS data
  publication-title: PLoS Comput Biol
– volume: 12
  start-page: 207
  year: 2013
  end-page: 16
  ident: CR5
  article-title: Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers
  publication-title: Lancet Neurol
– volume: 55
  start-page: 306
  year: 2004
  end-page: 19
  ident: CR8
  article-title: Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B
  publication-title: Ann Neurol
– volume: 3
  start-page: e02236
  year: 2014
  ident: CR50
  article-title: Ribosomal protein S27-like is a physiological regulator of p53 that suppresses genomic instability and tumorigenesis
  publication-title: Elife
– volume: 41
  start-page: e213
  year: 2016
  end-page: 200 e220
  ident: CR3
  article-title: Assessment of the genetic variance of late-onset Alzheimer’s disease
  publication-title: Neurobiol Aging
– volume: 67
  start-page: 122
  year: 2010
  end-page: 31
  ident: CR19
  article-title: APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging
  publication-title: Ann Neurol
– volume: 25
  start-page: 1528
  year: 2005
  end-page: 47
  ident: CR9
  article-title: Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B
  publication-title: J Cereb Blood Flow Metab
– volume: 467
  start-page: 1061
  year: 2010
  end-page: 73
  ident: CR27
  article-title: A map of human genome variation from population-scale sequencing
  publication-title: Nature
– volume: 51
  start-page: 2202
  year: 2013
  end-page: 9
  ident: CR18
  article-title: Cognitive aging in persons with minimal amyloid-beta and white matter hyperintensities
  publication-title: Neuropsychologia
– volume: 37
  start-page: 79
  year: 2014
  end-page: 100
  ident: CR34
  article-title: Apolipoprotein E in Alzheimer’s disease: an update
  publication-title: Annu Rev Neurosci
– volume: 10
  start-page: e1004269
  year: 2014
  ident: CR54
  article-title: Statistical power to detect genetic (co)variance of complex traits using SNP data in unrelated samples
  publication-title: PLoS Genet
– volume: 8
  start-page: 1
  year: 2012
  end-page: 13
  ident: CR4
  article-title: National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease
  publication-title: Alzheimers Dement
– volume: 11
  start-page: 964
  year: 2015
  end-page: 74
  ident: CR12
  article-title: Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer’s disease: phase 3 study
  publication-title: Alzheimers Dement
– volume: 4
  year: 2014
  ident: CR46
  article-title: Follow-up of loci from the International Genomics of Alzheimer’s Disease Project identifies TRIP4 as a novel susceptibility gene
  publication-title: Transl Psychiatry
– volume: 6
  start-page: 221
  year: 2010
  end-page: 9
  ident: CR22
  article-title: The Alzheimer’s Disease Neuroimaging Initiative positron emission tomography core
  publication-title: Alzheimers Dement
– volume: 37
  start-page: 896
  year: 2013
  end-page: 904
  ident: CR39
  article-title: Genetic markers of comorbid depression and alcoholism in women
  publication-title: Alcohol Clin Exp Res
– volume: 65
  start-page: 151
  year: 2015
  end-page: 4
  ident: CR44
  article-title: Death-associated protein kinase 2: regulator of apoptosis, autophagy and inflammation
  publication-title: Int J Biochem Cell Biol
– volume: 72
  start-page: 287
  year: 2015
  end-page: 94
  ident: CR13
  article-title: Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density
  publication-title: JAMA Neurol
– volume: 60
  start-page: 279
  year: 2017
  end-page: 83
  ident: CR48
  article-title: HERC1 mutations in idiopathic intellectual disability
  publication-title: Eur J Med Genet
– volume: 31
  start-page: 1208
  year: 2016
  end-page: 14
  ident: CR52
  article-title: Immunohistochemical analysis of ATRX, IDH1 and p53 in glioblastoma and their correlations with patient survival
  publication-title: J Korean Med Sci
– volume: 15
  start-page: 56
  year: 2016
  end-page: 64
  ident: CR6
  article-title: Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study
  publication-title: Lancet Neurol
– volume: 67
  start-page: 446
  year: 2006
  end-page: 52
  ident: CR25
  article-title: [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease
  publication-title: Neurology
– volume: 13
  start-page: 1542
  year: 2014
  end-page: 58
  ident: CR53
  article-title: Toll-like receptors in Alzheimer’s disease: a therapeutic perspective
  publication-title: CNS Neurol Disord Drug Targets
– volume: 17
  start-page: 1340
  year: 2012
  end-page: 6
  ident: CR15
  article-title: Genome-wide association analysis of age-at-onset in Alzheimer’s disease
  publication-title: Mol Psychiatry
– volume: 133
  start-page: 839
  year: 2017
  end-page: 56
  ident: CR33
  article-title: Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers
  publication-title: Acta Neuropathol
– volume: 31
  start-page: 352
  year: 2014
  end-page: 60
  ident: CR37
  article-title: A genome-wide association study of clinical symptoms of dissociation in a trauma-exposed sample
  publication-title: Depress Anxiety
– volume: 45
  start-page: 1452
  year: 2013
  end-page: 8
  ident: CR2
  article-title: Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease
  publication-title: Nat Genet
– volume: 71
  start-page: 1394
  year: 2014
  end-page: 404
  ident: CR16
  article-title: Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study
  publication-title: JAMA Neurol
– volume: 49
  start-page: 1392
  year: 2017
  end-page: 7
  ident: CR43
  article-title: Genetic analysis in UK Biobank links insulin resistance and transendothelial migration pathways to coronary artery disease
  publication-title: Nat Genet
– volume: 6
  start-page: 84
  year: 2016
  end-page: 93
  ident: CR23
  article-title: [(11)C]PiB PET in Gerstmann-Straussler-Scheinker disease
  publication-title: Am J Nucl Med Mol Imaging
– volume: 26
  start-page: 2190
  year: 2010
  end-page: 1
  ident: CR28
  article-title: METAL: fast and efficient meta-analysis of genomewide association scans
  publication-title: Bioinformatics
– volume: 168
  start-page: 104
  year: 2018
  end-page: 127
  ident: CR51
  article-title: The interactions of p53 with tau and Ass as potential therapeutic targets for Alzheimer’s disease
  publication-title: Prog Neurobiol
– volume: 11
  start-page: 867
  year: 2016
  end-page: 72
  ident: CR41
  article-title: Long noncoding RNAs and Alzheimer’s disease
  publication-title: Clin Interv Aging
– volume: 5
  start-page: e1000529
  year: 2009
  ident: CR26
  article-title: A flexible and accurate genotype imputation method for the next generation of genome-wide association studies
  publication-title: PLoS Genet
– volume: 104
  start-page: 4159
  year: 2007
  end-page: 64
  ident: CR47
  article-title: Regulation of Alzheimer’s disease amyloid-beta formation by casein kinase I
  publication-title: Proc Natl Acad Sci USA
– volume: 126
  start-page: 643
  year: 2013
  end-page: 57
  ident: CR10
  article-title: Cerebral amyloid PET imaging in Alzheimer’s disease
  publication-title: Acta Neuropathol
– volume: 11
  start-page: 669
  year: 2012
  end-page: 78
  ident: CR11
  article-title: Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: a prospective cohort study
  publication-title: Lancet Neurol
– volume: 168
  start-page: 427
  year: 2017
  end-page: 41 e421
  ident: CR35
  article-title: ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and abeta secretion
  publication-title: Cell
– volume: 43
  start-page: 436
  year: 2011
  end-page: 41
  ident: CR1
  article-title: Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease
  publication-title: Nat Genet
– volume: 15
  start-page: 1044
  year: 2016
  end-page: 53
  ident: CR7
  article-title: Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer’s disease pathophysiology (SNAP) or Alzheimer’s disease pathology: a longitudinal study
  publication-title: Lancet Neurol
– volume: 40
  start-page: 662
  year: 2016
  end-page: 74
  ident: CR38
  article-title: Genome-wide association studies suggest sex-specific loci associated with abdominal and visceral fat
  publication-title: Int J Obes (Lond)
– volume: 6
  start-page: 1
  year: 2012
  end-page: 15
  ident: CR20
  article-title: Amyloid pathway-based candidate gene analysis of [(11)C]PiB-PET in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort
  publication-title: Brain Imaging Behav
– volume: 11
  start-page: 792
  year: 2015
  end-page: 814
  ident: CR21
  article-title: Genetic studies of quantitative MCI and AD phenotypes in ADNI: progress, opportunities, and plans
  publication-title: Alzheimers Dement
– volume: 2
  year: 2012
  ident: CR29
  article-title: Genome-wide association study of Alzheimer’s disease
  publication-title: Transl Psychiatry
– volume: 96
  start-page: 1024
  year: 2017
  end-page: 32
  ident: CR36
  article-title: ApoE4 accelerates early seeding of amyloid pathology
  publication-title: Neuron
– volume: 61
  start-page: 199
  year: 2016
  end-page: 206
  ident: CR49
  article-title: Whole-exome sequencing and neurite outgrowth analysis in autism spectrum disorder
  publication-title: J Hum Genet
– volume: 152
  start-page: 1298
  year: 2013
  end-page: 307
  ident: CR40
  article-title: Long noncoding RNAs: cellular address codes in development and disease
  publication-title: Cell
– volume: 19
  start-page: 351
  year: 2014
  end-page: 7
  ident: CR32
  article-title: APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study
  publication-title: Mol Psychiatry
– volume: 73
  start-page: 751
  year: 2013
  end-page: 61
  ident: CR17
  article-title: In vivo assessment of amyloid-beta deposition in nondemented very elderly subjects
  publication-title: Ann Neurol
– volume: 5
  start-page: 11
  year: 2013
  ident: CR24
  article-title: The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)
  publication-title: Front Aging Neurosci
– volume: 36
  start-page: 297
  year: 2015
  end-page: 309
  ident: CR14
  article-title: Amyloid biomarkers in Alzheimer’s disease
  publication-title: Trends Pharmacol Sci
– volume: 71
  start-page: 207
  year: 2013
  end-page: 15
  ident: CR30
  article-title: Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches
  publication-title: Neuroimage
– volume: 132
  start-page: 160
  year: 2017
  end-page: 9
  ident: CR42
  article-title: Long non-coding RNAs in brain development, synaptic biology, and Alzheimer’s disease
  publication-title: Brain Res Bull
– volume: 11
  start-page: 669
  year: 2012
  ident: 246_CR11
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(12)70142-4
– volume: 40
  start-page: 662
  year: 2016
  ident: 246_CR38
  publication-title: Int J Obes (Lond)
  doi: 10.1038/ijo.2015.217
– volume: 6
  start-page: 221
  year: 2010
  ident: 246_CR22
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2010.03.003
– volume: 126
  start-page: 643
  year: 2013
  ident: 246_CR10
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-013-1185-7
– volume: 36
  start-page: 297
  year: 2015
  ident: 246_CR14
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/j.tips.2015.03.002
– volume: 132
  start-page: 160
  year: 2017
  ident: 246_CR42
  publication-title: Brain Res Bull
  doi: 10.1016/j.brainresbull.2017.03.010
– volume: 8
  start-page: 1
  year: 2012
  ident: 246_CR4
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2011.10.007
– volume: 73
  start-page: 751
  year: 2013
  ident: 246_CR17
  publication-title: Ann Neurol
  doi: 10.1002/ana.23797
– volume: 12
  start-page: 207
  year: 2013
  ident: 246_CR5
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(12)70291-0
– volume: 6
  start-page: 84
  year: 2016
  ident: 246_CR23
  publication-title: Am J Nucl Med Mol Imaging
– volume: 19
  start-page: 351
  year: 2014
  ident: 246_CR32
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2013.19
– volume: 67
  start-page: 122
  year: 2010
  ident: 246_CR19
  publication-title: Ann Neurol
  doi: 10.1002/ana.21843
– volume: 467
  start-page: 1061
  year: 2010
  ident: 246_CR27
  publication-title: Nature
  doi: 10.1038/nature09534
– volume: 168
  start-page: 104
  year: 2018
  ident: 246_CR51
  publication-title: Prog Neurobiol
  doi: 10.1016/j.pneurobio.2018.05.001
– volume: 31
  start-page: 1208
  year: 2016
  ident: 246_CR52
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2016.31.8.1208
– volume: 11
  start-page: 792
  year: 2015
  ident: 246_CR21
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2015.05.009
– volume: 37
  start-page: 79
  year: 2014
  ident: 246_CR34
  publication-title: Annu Rev Neurosci
  doi: 10.1146/annurev-neuro-071013-014300
– volume: 15
  start-page: 1044
  year: 2016
  ident: 246_CR7
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(16)30125-9
– volume: 71
  start-page: 1394
  year: 2014
  ident: 246_CR16
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2014.1491
– volume: 43
  start-page: 436
  year: 2011
  ident: 246_CR1
  publication-title: Nat Genet
  doi: 10.1038/ng.801
– volume: 96
  start-page: 1024
  year: 2017
  ident: 246_CR36
  publication-title: Neuron
  doi: 10.1016/j.neuron.2017.11.013
– volume: 61
  start-page: 199
  year: 2016
  ident: 246_CR49
  publication-title: J Hum Genet
  doi: 10.1038/jhg.2015.141
– volume: 13
  start-page: 1542
  year: 2014
  ident: 246_CR53
  publication-title: CNS Neurol Disord Drug Targets
  doi: 10.2174/1871527313666140806124850
– volume: 55
  start-page: 306
  year: 2004
  ident: 246_CR8
  publication-title: Ann Neurol
  doi: 10.1002/ana.20009
– volume: 5
  start-page: 11
  year: 2013
  ident: 246_CR24
  publication-title: Front Aging Neurosci
  doi: 10.3389/fnagi.2013.00011
– volume: 31
  start-page: 352
  year: 2014
  ident: 246_CR37
  publication-title: Depress Anxiety
  doi: 10.1002/da.22260
– volume: 51
  start-page: 2202
  year: 2013
  ident: 246_CR18
  publication-title: Neuropsychologia
  doi: 10.1016/j.neuropsychologia.2013.07.017
– volume: 25
  start-page: 1528
  year: 2005
  ident: 246_CR9
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1038/sj.jcbfm.9600146
– volume: 11
  start-page: e1004219
  year: 2015
  ident: 246_CR31
  publication-title: PLoS Comput Biol
  doi: 10.1371/journal.pcbi.1004219
– volume: 49
  start-page: 1392
  year: 2017
  ident: 246_CR43
  publication-title: Nat Genet
  doi: 10.1038/ng.3914
– volume: 3
  start-page: e02236
  year: 2014
  ident: 246_CR50
  publication-title: Elife
  doi: 10.7554/eLife.02236
– volume: 168
  start-page: 427
  year: 2017
  ident: 246_CR35
  publication-title: Cell
  doi: 10.1016/j.cell.2016.12.044
– volume: 10
  start-page: e1004269
  year: 2014
  ident: 246_CR54
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1004269
– volume: 6
  start-page: 1
  year: 2012
  ident: 246_CR20
  publication-title: Brain Imaging Behav
  doi: 10.1007/s11682-011-9136-1
– volume: 67
  start-page: 446
  year: 2006
  ident: 246_CR25
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000228230.26044.a4
– volume: 25
  start-page: 2498
  year: 2016
  ident: 246_CR45
  publication-title: Hum Mol Genet
– volume: 45
  start-page: 1452
  year: 2013
  ident: 246_CR2
  publication-title: Nat Genet
  doi: 10.1038/ng.2802
– volume: 37
  start-page: 896
  year: 2013
  ident: 246_CR39
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/acer.12060
– volume: 65
  start-page: 151
  year: 2015
  ident: 246_CR44
  publication-title: Int J Biochem Cell Biol
  doi: 10.1016/j.biocel.2015.06.001
– volume: 152
  start-page: 1298
  year: 2013
  ident: 246_CR40
  publication-title: Cell
  doi: 10.1016/j.cell.2013.02.012
– volume: 26
  start-page: 2190
  year: 2010
  ident: 246_CR28
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btq340
– volume: 104
  start-page: 4159
  year: 2007
  ident: 246_CR47
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0611236104
– volume: 11
  start-page: 964
  year: 2015
  ident: 246_CR12
  publication-title: Alzheimers Dement
  doi: 10.1016/j.jalz.2015.02.004
– volume: 5
  start-page: e1000529
  year: 2009
  ident: 246_CR26
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1000529
– volume: 72
  start-page: 287
  year: 2015
  ident: 246_CR13
  publication-title: JAMA Neurol
  doi: 10.1001/jamaneurol.2014.4144
– volume: 2
  year: 2012
  ident: 246_CR29
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2012.45
– volume: 71
  start-page: 207
  year: 2013
  ident: 246_CR30
  publication-title: Neuroimage
  doi: 10.1016/j.neuroimage.2013.01.015
– volume: 11
  start-page: 867
  year: 2016
  ident: 246_CR41
  publication-title: Clin Interv Aging
  doi: 10.2147/CIA.S107037
– volume: 41
  start-page: e213
  year: 2016
  ident: 246_CR3
  publication-title: Neurobiol Aging
  doi: 10.1016/j.neurobiolaging.2016.02.024
– volume: 60
  start-page: 279
  year: 2017
  ident: 246_CR48
  publication-title: Eur J Med Genet
  doi: 10.1016/j.ejmg.2017.03.007
– volume: 15
  start-page: 56
  year: 2016
  ident: 246_CR6
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(15)00323-3
– volume: 4
  year: 2014
  ident: 246_CR46
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2014.2
– volume: 17
  start-page: 1340
  year: 2012
  ident: 246_CR15
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2011.135
– volume: 133
  start-page: 839
  year: 2017
  ident: 246_CR33
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-017-1685-y
SSID ssj0014765
Score 2.5298722
SecondaryResourceType review_article
Snippet Deposition of amyloid plaques in the brain is one of the two main pathological hallmarks of Alzheimer’s disease (AD). Amyloid positron emission tomography...
Deposition of amyloid plaques in the brain is one of the two main pathological hallmarks of Alzheimer's disease (AD). Amyloid positron emission tomography...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 309
SubjectTerms 45
45/43
631/208
631/477
Alzheimer Disease - diagnostic imaging
Alzheimer Disease - genetics
Alzheimer Disease - metabolism
Alzheimer's disease
Amyloid beta-Peptides - metabolism
Amyloid beta-protein
Aniline Compounds - analysis
Apolipoprotein E
Apolipoprotein E4 - genetics
Apolipoproteins
Behavioral Sciences
Biological Psychology
Brain
Brain - diagnostic imaging
Brain - metabolism
Cerebrospinal fluid
Development and progression
Endophenotypes
Female
Genetic aspects
Genetic diversity
Genome-wide association studies
Genome-Wide Association Study
Genomes
Health aspects
Humans
Identification and classification
Linkage disequilibrium
Male
Medicine
Medicine & Public Health
Neurodegenerative diseases
Neuroimaging
Neurosciences
PET imaging
Pharmacotherapy
Physiological aspects
Polymorphism, Single Nucleotide - genetics
Positron emission tomography
Psychiatry
Quantitative trait loci
Senile plaques
Single-nucleotide polymorphism
Systematic review
Thiazoles - analysis
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3ra9RAEB9qi-AX8W20ygqCL5bmNpvXB5GeXC2CxyEt9NuSfQQDXnLtpUj_e2c2j_MO7NfsJGx2nrsz-xuAt5pAzVEweFiGhmNEbDldkORhHDsb6mRS-AP9H_Pk9Fx-v4gv9mA-3IWhssrBJnpDbRtDZ-RHgnDekwz90ZfVJaeuUZRdHVpoFH1rBfvZQ4zdgQM0yRnK_cF0Nl_8HPMKMvXNJSdRTPnPTA55zig7WqM5z6hIC-ctZMLTLU-1a6__cVi7xZQ7GVXvqE4ewP0-wmTHnUg8hD1XP4K7Xc_Jm8ew-ubqZun4n8o6VmyYwzzQLGtKpqlrBCuWuJWvLLNuqOtCarbsjhQt0zdsUbXt2mdpGFkV6s_Ep-z9opp-4IvZGauWvgPSEzg_mZ19PeV92wVu4ihtuc7CCKOqwqRC5NI6spexDgvc-Ok8LmVupCbHN4kweqSQMS6Fo8Ahcik-ldFT2K-b2j0HFgljQ1OgEcnRC5q8EI4yo6mQmS5TYwIIhyVWpsckp9YYv5XPjUeZ6riikCuKuKLSAD6Or6w6QI7biN8R3xQpK37XFP2dA5wdwV6p44QQyHDXGwZwuEWJSma2hwfOq17J12ojkgG8GYfpTSpcq11zjTQTQVDQuCkO4FknKOO0_SKiegSQbonQSEDQ39sjdfXLQ4An6GhkIgP4NAjbZlr_XY0Xt__ES7gnqGDHny8dwn57de1eYcTV6te9Gv0F-pcjpQ
  priority: 102
  providerName: ProQuest
Title Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging
URI https://link.springer.com/article/10.1038/s41380-018-0246-7
https://www.ncbi.nlm.nih.gov/pubmed/30361487
https://www.proquest.com/docview/2478868812
https://www.proquest.com/docview/2126906917
https://pubmed.ncbi.nlm.nih.gov/PMC6219464
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3ra9swED_6YGNfxta9vHVBg8FeiNmybNkf45CsDBrCaCHfjC3L1LA4ZXEZ_e93Jz86Z2ywT4HoLITuKd3pdwBvcwI1R8HgbulqjhFxwemBJHeDwBRuHnqZvdA_X4Znl_LrOlgfgNe_hbFF-xbS0prpvjrs8w6NbUQlVDirkCFXh3Ac4bGOhHoWzobEgVS2e6TnB5TgjGSfyPSjP6cYuaJ9g_ybR9qvltxLmVpPtHgED7sQkk3bRT-GA1OfwL22qeTtCdw_79LlT-D6i6m3G8N_VoVh2R0jmAWVZduS5dQhgmUbPLZXBStMX8OF1GzTXh8WLL9lq6ppdjYjw8iCUC8mnrD3qyr5wFfzC1ZtbLejp3C5mF_MznjXYoHrwFcNzyPXxwgq00qIWBaGbGOQuxke8vI4KGWsZU5OzvMxUqTwMCiFoSDBNwr_lf4zOKq3tXkBzBe6cHWGBiNGj6fjTBjKgioho7xUWjvg9rud6g5_nNpgfE9tHtyP0pZBKTIoJQalyoGPwyfXLfjGv4jfEQtTUkycV2fd-wJcHUFcpdOQ0MbwhOs6cDqiRIXS4-FeCNJOoXepoDYDYYThkANvhmH6korUarO9QRpPEOwzHoAdeN7KzLBsu4moCg6okTQNBATzPR6pqysL9x2iU5GhdOBTL3d3y_rrbrz8L-pX8EBQrY69WjqFo-bHjXmNwVaTT-BQrdUEjqeLJFnibzJfrr5NrNL9ArfZIYg
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3rb9MwED-NTgi-IN4EBhgJxEvWUsd59MOEVujo2FZVqJP2zSSOKyKtSaGdpv5z_G3cOY-SSuzbvsaXyPGd7-E7_w7gdUKg5igY3J26mqNHnHK6IMld3zepmwTd2B7on4yC4an8duafbcGf-i4MlVXWOtEq6rTQdEa-KwjnPYjQHn2a_-LUNYqyq3ULjbhqrZDuWYix6mLHkVldYgi32Dv8gvx-I8TBYPJ5yKsuA1z7XrjkSeR66ETEOhSiJ1ND6sFP3BjjnKTnT2VPy4T0fNdDZ4k8JH8qDNlJz4T4VHr43RuwLemGawe2-4PR-HuTx5ChbWbZxUEuMZiq86petLtA8xFRURiuk5ABD1uWcdM-_GMgN4s3NzK41jAe3IU7lUfL9ksRvAdbJr8PN8sel6sHMP9q8mJm-GWWGhavhYFZYFtWTFlCXSpYPFudF1nKUlPXkSE1m5VHmClLVmycLZcLmxVipMWoHxTvs3fjrP-ejwcTls1sx6WHcHotDHgEnbzIzRNgntCpq2NUWj20uroXC0OZ2FDIKJmGWjvg1kusdIWBTq04zpXNxXuRKrmikCuKuKJCBz40r8xLAJCriN8S3xQpB_yujqs7Djg7gtlS-wEhnmGU7Tqw06LETa3bwzXnVaVUFmq9BRx41QzTm1Qol5viAmm6gqCnMQh34HEpKM207SLidnQgbIlQQ0BQ4-2RPPtpIccDNGwykA58rIVtPa3_rsbTq3_iJdwaTk6O1fHh6OgZ3BZULGTPtnags_x9YZ6jt7dMXlRbisGP697FfwF2JFx8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTiBeEN8EBhgJBAxZTR3n62FCK2vZGFQV2qS9mcRxRKQ1KbTT1H-Rv4o7J2lpJfa21_gSOb5P-86_A3idEqg5CgZ3c1dzjIgzThckuev7JnPToJfYA_1vo-DwVH4588-24E97F4bKKlubaA11Vmk6I-8KwnkPIvRH3bwpixgfDD9Of3HqIEWZ1radRtK0Wcj2LNxYc8nj2CwucTs32zs6QN6_EWI4OPl0yJuOA1z7XjjnaeR6GFAkOhQilpkhU-GnboJ7njT2cxlrmZLN73kYOFG05OfCkM_0TIhPpYffvQHbIXpJ2YHt_mA0_r7MacjQNrbseT7lXiPZ5li9qDtDVxJRgRiumZABD9e85Kav-MdZbhZybmRzrZMc3oU7TXTL9mtxvAdbprwPN-t-l4sHMP1sympi-GWRGZasBINZkFtW5SyljhUsmSzOqyJjmWlrypCaTerjzIylCzYu5vOZzRAxsmjUG4r32btx0X_Px4MTVkxs96WHcHotDHgEnbIqzRNgntCZqxM0YDF6YB0nwlBWNhQySvNQawfcdomVbvDQqS3HubJ5eS9SNVcUckURV1TowO7ylWkNBnIV8VvimyJDgd_VSXPfAWdHkFtqPyD0M9xxuw7srFGiguv14ZbzqjEwM7VSBwdeLYfpTSqaK011gTQ9QTDUuCF34HEtKMtp20VE1XQgXBOhJQHBjq-PlMVPCz8eoJOTgXTgQytsq2n9dzWeXv0TL-EWarP6ejQ6fga3BdUN2WOuHejMf1-Y5xj4zdMXjUYx-HHdSvwXIV1gqA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Genome-wide+association+study+of+brain+amyloid+deposition+as+measured+by+Pittsburgh+Compound-B+-PET+imaging&rft.jtitle=Molecular+psychiatry&rft.au=Yan%2C+Qi&rft.au=Nho%2C+Kwangsik&rft.au=Del-Aguila%2C+Jorge+L&rft.au=Wang%2C+Xingbin&rft.date=2021-01-01&rft.pub=Nature+Publishing+Group&rft.issn=1359-4184&rft.volume=26&rft.issue=1&rft.spage=309&rft_id=info:doi/10.1038%2Fs41380-018-0246-7&rft.externalDocID=A655702100
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1359-4184&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1359-4184&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1359-4184&client=summon